Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.

Autor: Jones KM; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Mangin EN; Department of Molecular Physiology, Baylor College of Medicine, Houston, TX, United States., Reynolds CL; Department of Molecular Physiology, Baylor College of Medicine, Houston, TX, United States., Villanueva LE; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Laboratorio de Parasitología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico., Cruz JV; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Laboratorio de Parasitología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico., Versteeg L; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Cell Biology and Immunology Group, Wageningen University & Research, Wageningen, Netherlands., Keegan B; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Kendricks A; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Pollet J; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Gusovsky F; Global Health Research, Eisai, Inc., Cambridge, MA, United States., Bottazzi ME; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.; Department of Biology, Baylor University, Waco, TX, United States., Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.; Department of Biology, Baylor University, Waco, TX, United States.; James A. Baker III Institute for Public Policy, Rice University, Houston, TX, United States.; Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, United States.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Feb 09; Vol. 13, pp. 1106315. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).